Recombinant Human AP2A2 293 Cell Lysate
Cat.No. : | AP2A2-8816HCL |
- Specification
- Gene Information
- Related Products
- Download
Description : | Antigen standard for adaptor-related protein complex 2, alpha 2 subunit (AP2A2) is a lysate prepared from HEK293T cells transiently transfected with a TrueORF gene-carrying pCMV plasmid and then lysed in RIPA Buffer. Protein concentration was determined using a colorimetric assay. The antigen control carries a C-terminal Myc/DDK tag for detection. |
Source : | HEK 293 cells |
Species : | Human |
Components : | This product includes 3 vials: 1 vial of gene-specific cell lysate, 1 vial of control vector cell lysate, and 1 vial of loading buffer. Each lysate vial contains 0.1 mg lysate in 0.1 ml (1 mg/ml) of RIPA Buffer (50 mM Tris-HCl pH7.5, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1% NP40). The loading buffer vial contains 0.5 ml 2X SDS Loading Buffer (125 mM Tris-Cl, pH6.8, 10% glycerol, 4% SDS, 0.002% Bromophenol blue, 5% beta-mercaptoethanol). |
Size : | 0.1 mg |
Storage Instruction : | Store at -80°C. Minimize freeze-thaw cycles. After addition of 2X SDS Loading Buffer, the lysates can be stored at -20°C. Product is guaranteed 6 months from the date of shipment. |
Applications : | ELISA, WB, IP. WB: Mix equal volume of lysates with 2X SDS Loading Buffer. Boil the mixture for 10 min before loading (for membrane protein lysates, incubate the mixture at room temperature for 30 min). Load 5 ug lysate per lane. |
Tag : | Non |
Gene Name : | AP2A2 adaptor-related protein complex 2, alpha 2 subunit [ Homo sapiens ] |
Official Symbol : | AP2A2 |
Synonyms : | AP2A2; adaptor-related protein complex 2, alpha 2 subunit; ADTAB, CLAPA2; AP-2 complex subunit alpha-2; adaptin; alpha B; alpha adaptin C; Huntingtin interacting protein J; clathrin associated/assembly/adaptor protein; large; alpha 2; DKFZP564D1864; HIP9; HYPJ; KIAA0899; alpha2-adaptin; adaptin, alpha B; huntingtin yeast partner J; 100 kDa coated vesicle protein C; huntingtin-interacting protein 9; alpha-adaptin C; Huntingtin interacting protein J; clathrin assembly protein complex 2 alpha-C large chain; plasma membrane adaptor HA2/AP2 adaptin alpha C subunit; clathrin-associated/assembly/adaptor protein, large, alpha 2; ADTAB; HIP-9; CLAPA2; FLJ37177; |
Gene ID : | 161 |
mRNA Refseq : | NM_001242837 |
Protein Refseq : | NP_001229766 |
MIM : | 607242 |
UniProt ID : | O94973 |
Chromosome Location : | 11p15.5 |
Pathway : | Axon guidance, organism-specific biosystem; Developmental Biology, organism-specific biosystem; Disease, organism-specific biosystem; EGFR downregulation, organism-specific biosystem; Endocrine and other factor-regulated calcium reabsorption, organism-specific biosystem; Endocrine and other factor-regulated calcium reabsorption, conserved biosystem; Endocytosis, organism-specific biosystem; |
Function : | lipid binding; molecular_function; protein transporter activity; |
Products Types
◆ Recombinant Protein | ||
AP2A2-601M | Recombinant Mouse AP2A2 Protein, His (Fc)-Avi-tagged | +Inquiry |
AP2A2-2111C | Recombinant Chicken AP2A2 | +Inquiry |
AP2A2-9715H | Recombinant Human AP2A2, His-tagged | +Inquiry |
AP2A2-1739M | Recombinant Mouse AP2A2 Protein | +Inquiry |
Ap2a2-3531R | Recombinant Rat Ap2a2, His-tagged | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Reviews
- Q&As
Customer Reviews (4)
Write a reviewThe sensitivity of AP2A2 in Western blot is very high, and low concentrations of the target protein can be detected.
I appreciate the production process of AP2A2, every step is strictly controlled to ensure the quality and repeatability of the product.
Under different pH conditions, the stability of this protein is still very good, indicating that it has excellent acid-base stability.
AP2A2 are structurally stable and not prone to mutation.
Q&As (19)
Ask a questionRecombinant AP2A2 may play an antitumor role by inhibiting tumor growth and promoting autoimmunity.
Normally, AP2A2 injections should be stored in the refrigerator at a temperature of 2-8 ° C.
Recombinant AP2A2 therapy can be administered intravenously or intramuscularly.
Generally, the preparation methods of AP2A2 include recombinant DNA technology and protein expression and purification technology.
At present, the recombinant AP2A2 protein is still in clinical trials, and researchers are evaluating its safety and efficacy.
There are no clear studies showing that the AP2A2 improves patients' quality of life, but its therapeutic effect may vary for individuals.
Recombinant AP2A2 protein may regulate immune cell activity and enhance immune response, but the specific mechanism still needs to be further studied.
While some studies have shown that recombinant AP2A2 has a preventive effect, more research is needed to confirm its effectiveness.
The study of AP2A2 still faces challenges in terms of safety, efficacy and stability.
Although some preliminary studies suggest that recombinant AP2A2 may have a therapeutic effect on autoimmune diseases, more clinical trials are needed to determine its efficacy.
Evaluation of the effectiveness of AP2A2 therapy usually includes clinical symptom improvement, biomarker level detection, etc.
No definite side effects have been reported, but please consult your doctor before receiving treatment.
The indication for the treatment of AP2A2 needs to be determined based on the specific disease and individual patient situation. Consult your doctor for more accurate advice.
The duration of treatment for AP2A2 varies according to the purpose of treatment and individual differences, please consult your doctor for details.
Currently, the AP2A2 shows potential in the treatment of certain cancers and autoimmune diseases.
There is no clear clinical limit to its use, but different diseases and individual conditions may affect its therapeutic effectiveness.
There are no clear studies showing that recombinant AP2A2 has a therapeutic effect on non-immune-related diseases.
Recombinant protein AP2A2 is mainly involved in intracellular material transport and endocytosis.
Some studies have shown that recombinant AP2A2 can inhibit the growth and spread of certain cancer cells, but further clinical studies are needed to verify its therapeutic effect.
Ask a Question for All AP2A2 Products
Required fields are marked with *
My Review for All AP2A2 Products
Required fields are marked with *
Inquiry Basket